cancer therapeutics Market Research Reports

Titlepublishedprice

Adrenocortical Carcinoma (Adrenal Cortex Cancer) – Pipeline Review, H2 2014

By Global Markets Direct
"......tical Carcinoma (Adrenal Cortex Cancer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured......"
14-Nov-2014$2000

Liposarcoma – Pipeline Review, H2 2014

By Global Markets Direct
"......essment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liposarcoma a......"
14-Nov-2014$2000

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 – Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

By GBI Research
"...... gives an estimation of market size for 2013 along with forecasts until 2020 for the Asia-Pacific (APAC) region, which comprises Australia, China, India and Japan. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-dept......"
31-Oct-2014$4995

Indolent Lymphoma – Pipeline Review, H2 2014

By Global Markets Direct
"......therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development f......"
31-Oct-2014$2000

T-Cell Lymphomas – Pipeline Review, H2 2014

By Global Markets Direct
"......rapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for ......"
31-Oct-2014$2000

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 – New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

By GBI Research
"...... indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan and Canada. It also covers disease epidemiology, treatm......"
31-Oct-2014$4995

Osteosarcoma – Pipeline Review, H2 2014

By Global Markets Direct
"......sessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteosarcoma......"
31-Oct-2014$2000

Frontier Pharma: Non-Small Cell Lung Cancer – Identifying and Commercializing First-in-Class Innovation

By GBI Research
"......emotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. This diversity is partially due to the presence of 12......"
31-Oct-2014$6995

Metastatic Prostate Cancer – Pipeline Review, H2 2014

By Global Markets Direct
"......nalysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in th......"
31-Oct-2014$2000

Soft Tissue Sarcoma – Pipeline Review, H2 2014

By Global Markets Direct
"......ages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic develop......"
31-Oct-2014$2000
Live Chat
Live Chat by Comm100